THE DECISION: THE SCOPE OF GENUS CLAIMS
AMGEN V. SANOFI (2023) GUIDING CASE LAW
This decision emphasizes the importance of structural
characterization and representative species in biotech patent applications. Simply claiming a function (e.g., "antibodies that bind to PCSK9") without providing a diverse set of well- characterized embodiments can doom a patent's validity.
Made with FlippingBook Annual report maker